We are live on ! Find out more
KBG

Kahn Brothers Group Portfolio holdings

AUM $564M
1-Year Est. Return 25.3%
This Fund
S&P 500
This Quarter Est. Return
+0.88%
1 Year Est. Return
+25.3%
3 Year Est. Return
+38.07%
5 Year Est. Return
+72.96%
10 Year Est. Return
+308.37%
AUM
$581M
AUM Growth
-$14.4M
Cap. Flow
-$20.8M
Cap. Flow %
-3.58%
Top 10 Hldgs %
80.96%
Holding
55
New
3
Increased
12
Reduced
22
Closed
2

Top Sells

Rank Stock Value
1
MBI icon
MBIA
MBI
+$30.6M
2
GSK icon
GSK
GSK
+$7.46M
3
VOXX
VOXX International Corporation Class A
VOXX
+$6.41M
4
BP icon
BP
BP
+$1.74M
5
MRK icon
Merck
MRK
+$1.36M

Sector Composition

Rank Sector Weight
1 Healthcare 45.95%
2 Financials 25.73%
3 Energy 12.04%
4 Communication Services 8.98%
5 Consumer Staples 5.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
C icon
1
Citigroup
C
$217B
$74.3M 12.79%
1,186,573
-8,279
-0.7% -$512K
MRK icon
2
Merck
MRK
$315B
$65.9M 11.35%
580,488
-11,423
-2% -$1.36M
BP icon
3
BP
BP
$108B
$49.9M 8.59%
1,588,880
-51,522
-3% -$1.74M
FLG
4
Flagstar Bank National Association
FLG
$6.21B
$47.2M 8.14%
4,207,166
+136,632
+3% +$1.45M
BAY
5
DELISTED
BAYER AG SPONS ADR
BAY
$43.7M 7.53%
5,159,540
+785,085
+18% +$6.65M
GSK icon
6
GSK
GSK
$104B
$43.3M 7.46%
1,058,832
-182,429
-15% -$7.46M
BMY icon
7
Bristol-Myers Squibb
BMY
$124B
$42.7M 7.36%
826,108
-1,150
-0.1% -$53.9K
DIS icon
8
Walt Disney
DIS
$170B
$39M 6.72%
405,445
+184,542
+84% +$17M
OGN icon
9
Organon & Co
OGN
$3.55B
$35.1M 6.05%
1,835,193
+174,170
+10% +$3.61M
PFE icon
10
Pfizer
PFE
$143B
$28.9M 4.97%
997,025
-5,405
-0.5% -$158K
SEB icon
11
Seaboard Corp
SEB
$4.34B
$28.3M 4.88%
9,034
-191
-2% -$596K
AGO icon
12
Assured Guaranty
AGO
$3.76B
$23.5M 4.04%
294,985
-6,102
-2% -$481K
PTEN icon
13
Patterson-UTI
PTEN
$3.8B
$17.2M 2.96%
2,246,029
-74,825
-3% -$689K
IDT icon
14
IDT Corp
IDT
$1.57B
$12.6M 2.17%
330,228
-1,279
-0.4% -$47.5K
GNE icon
15
Genie Energy
GNE
$369M
$4.71M 0.81%
289,913
-1,752
-0.6% -$28.6K
HLN icon
16
Haleon
HLN
$44.5B
$2.56M 0.44%
241,952
-4,195
-2% -$40.6K
HOLX
17
DELISTED
Hologic
HOLX
$2.08M 0.36%
25,591
NVS icon
18
Novartis
NVS
$293B
$2.02M 0.35%
17,581
CSX icon
19
CSX Corp
CSX
$94.3B
$1.72M 0.3%
49,820
XOM icon
20
ExxonMobil
XOM
$611B
$1.68M 0.29%
14,326
FFH
21
DELISTED
FAIRFAX FINL HLDGS LTD SUB VTG
FFH
$1.29M 0.22%
1,018
WBS icon
22
Webster Financial
WBS
$12.3B
$999K 0.17%
21,437
+615
+3% +$28.2K
AR icon
23
Antero Resources
AR
$10.4B
$864K 0.15%
30,156
MSFT icon
24
Microsoft
MSFT
$2.93T
$792K 0.14%
1,839
+12
+0.7% +$5.13K
BAC icon
25
Bank of America
BAC
$430B
$737K 0.13%
18,576
-261
-1% -$10.5K

Similar funds

Kahn Brothers Group's Q3 2024 Portfolio in Review

As of Q3 2024, Kahn Brothers Group held 55 positions worth $581M, down 2.4% from $595M the previous quarter. Its ten largest holdings account for 81% of the portfolio.

Kahn Brothers Group withdrew a net $20.8M in Q3 2024, closing 2 positions and reducing 22 holdings. Its most notable exit was MBIA, an estimated $30.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, up from 43% a quarter earlier, followed by Financials and Energy.

Against the trend, Kahn Brothers Group opened a new position in SEI Investments worth $356K.

  • Kahn Brothers Group's largest Q3 2024 buy was SEI Investments: 5,147 shares worth $356K.
  • Kahn Brothers Group added most to Walt Disney in Q3 2024, an estimated $17M increase.
  • Kahn Brothers Group's biggest Q3 2024 reduction was GSK, cutting an estimated $7.46M.
  • Kahn Brothers Group fully exited MBIA in Q3 2024, selling an estimated $30.6M.
  • Kahn Brothers Group's ten largest holdings make up 81% of its $581M portfolio in Q3 2024.
  • Kahn Brothers Group opened 3 new positions and closed 2 in Q3 2024.
  • Kahn Brothers Group's portfolio value fell 2.4% quarter-over-quarter to $581M.

Based on Kahn Brothers Group's 13F filing for Q3 2024, filed 13 Nov 2024.